u/Green_Sport_8935 · 88d ago1 prior · awaiting results
“Still holding”
$IFRX is being slept on and I don't understand why
Six of seven analysts have price targets between $8–$9 with a recent Strong Buy from Raymond James. The company has secured $150M in financing and no near-term bankruptcy risk, with clinical data expected. The stock trades near $2, suggesting significant upside.